Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Treasury Shares (2021 - 2025)

PROCEPT BioRobotics has reported Treasury Shares over the past 5 years, most recently at $115000.0 for Q4 2025.

  • Quarterly results put Treasury Shares at $115000.0 for Q4 2025, up 41.98% from a year ago — trailing twelve months through Dec 2025 was $115000.0 (up 41.98% YoY), and the annual figure for FY2025 was $115000.0, up 41.98%.
  • Treasury Shares for Q4 2025 was $115000.0 at PROCEPT BioRobotics, roughly flat from $115000.0 in the prior quarter.
  • Over the last five years, Treasury Shares for PRCT hit a ceiling of $2.1 million in Q1 2025 and a floor of $35000.0 in Q4 2021.
  • Median Treasury Shares over the past 5 years was $1.4 million (2023), compared with a mean of $1.1 million.
  • Biggest five-year swings in Treasury Shares: soared 2020.0% in 2022 and later plummeted 94.82% in 2024.
  • PROCEPT BioRobotics' Treasury Shares stood at $35000.0 in 2021, then soared by 2020.0% to $742000.0 in 2022, then skyrocketed by 110.92% to $1.6 million in 2023, then plummeted by 94.82% to $81000.0 in 2024, then skyrocketed by 41.98% to $115000.0 in 2025.
  • The last three reported values for Treasury Shares were $115000.0 (Q4 2025), $115000.0 (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.